1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 29155058 | FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models. | 2018 Jan | 6 |